You are here

  • Home
  • Archive
  • Volume 6, Issue 3
  • Review: regular inhaled long acting β2 agonists are associated with better outcomes than short acting β2 agonists in adults and children with chronic asthma

Article info

Article menu
Download PDFPDF
Treatment
Review: regular inhaled long acting β2 agonists are associated with better outcomes than short acting β2 agonists in adults and children with chronic asthma
View Full Text

Citation

Review: regular inhaled long acting β2 agonists are associated with better outcomes than short acting β2 agonists in adults and children with chronic asthma
Evidence-Based Nursing 2003;6:76.

Publication history

  • First published July 1, 2003.
Online issue publication 
August 31, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2003 by the RCN Publishing Company and BMJ Publishing Group for Evidence-Based Nursing